GB0502961A
GB0502961D0
(en)
|
2005-02-12 |
2005-02-12 |
Chemical compounds
|
TW094117058A
TW200600086A
(en)
|
2004-06-05 |
2005-05-25 |
Chemical compound
|
KR1020067027324A
KR20070024650A
(en)
|
2004-06-05 |
2005-06-01 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
AU2005251990A
AU2005251990B2
(en)
|
2004-06-05 |
2005-06-01 |
Hetroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
MXPA06014128A
MXPA06014128A
(en)
|
2004-06-05 |
2005-06-01 |
Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes.
|
EP05747241A
EP1756076B1
(en)
|
2004-06-05 |
2005-06-01 |
Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
BRPI0511808-5A
BRPI0511808A
(en)
|
2004-06-05 |
2005-06-01 |
compound or a salt, prodrug or solvate thereof, use of a compound method for treating glk-mediated diseases, and process for the preparation of a compound
|
DE602005022859T
DE602005022859D1
(en)
|
2004-06-05 |
2005-06-01 |
Heteroarylbenzamide derivatives for use as glk activators in the treatment of diabetic
|
AT05747241T
ATE477249T1
(en)
|
2004-06-05 |
2005-06-01 |
HETEROARYLBENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES
|
US11/628,448
US7745475B2
(en)
|
2004-06-05 |
2005-06-01 |
Heteroaryl benzamide derivatives as GLK activators
|
CA002566951A
CA2566951A1
(en)
|
2004-06-05 |
2005-06-01 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
PCT/GB2005/002166
WO2005121110A1
(en)
|
2004-06-05 |
2005-06-01 |
Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
EP08154684A
EP1992623A1
(en)
|
2004-06-05 |
2005-06-01 |
Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes
|
ES05747241T
ES2347451T3
(en)
|
2004-06-05 |
2005-06-01 |
DERIVATIVES OF HETEROARIL BENZAMIDA FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES.
|
NZ551623A
NZ551623A
(en)
|
2004-06-05 |
2005-06-01 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
JP2007514127A
JP4860606B2
(en)
|
2004-06-05 |
2005-06-01 |
Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
|
ARP050102265A
AR049139A1
(en)
|
2004-06-05 |
2005-06-02 |
COMPOUNDS DERIVED FROM BENZAMIDS N - HETEROCICLIL - REPLACED AS ACTIVATORS OF GLUCOQUINASE (GLK), METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE AS A MEDICATION IN THE TREATMENT OF TYPE II DIABETES.
|
MYPI20052532A
MY144048A
(en)
|
2004-06-05 |
2005-06-02 |
Chemical compound
|
UY28936A
UY28936A1
(en)
|
2004-06-05 |
2005-06-02 |
GROUP OF BENZOIL-AMINO-HETEROCICLILO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, USEFUL FOR TREATMENT OF GLUCOQUINASE-AIDED DISEASES (GQ)
|
IL179389A
IL179389A0
(en)
|
2004-06-05 |
2006-11-19 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
NO20070032A
NO20070032L
(en)
|
2004-06-05 |
2007-01-03 |
Hetroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
|
HK07106859.0A
HK1102091A1
(en)
|
2004-06-05 |
2007-06-27 |
Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
US12/336,170
US20090253676A1
(en)
|
2004-06-05 |
2008-12-16 |
Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
|